PT - JOURNAL ARTICLE AU - Danilova, Nadia AU - Bibikova, Elena AU - Covey, Todd M. AU - Nathanson, David AU - Dimitrova, Elizabeth AU - Konto, Yoan AU - Lindgren, Anne AU - Glader, Bertil AU - Radu, Caius G. AU - Sakamoto, Kathleen M. AU - Lin, Shuo TI - The role of the DNA damage response in zebrafish and cellular models of Diamond Blackfan anemia AID - 10.1242/dmm.015495 DP - 2014 Jul 01 TA - Disease Models & Mechanisms PG - 895--905 VI - 7 IP - 7 4099 - http://dmm.biologists.org/content/7/7/895.short 4100 - http://dmm.biologists.org/content/7/7/895.full SO - Dis Models Mech2014 Jul 01; 7 AB - Ribosomal biogenesis involves the processing of pre-ribosomal RNA. A deficiency of some ribosomal proteins (RPs) impairs processing and causes Diamond Blackfan anemia (DBA), which is associated with anemia, congenital malformations and cancer. p53 mediates many features of DBA, but the mechanism of p53 activation remains unclear. Another hallmark of DBA is the upregulation of adenosine deaminase (ADA), indicating changes in nucleotide metabolism. In RP-deficient zebrafish, we found activation of both nucleotide catabolism and biosynthesis, which is consistent with the need to break and replace the faulty ribosomal RNA. We also found upregulation of deoxynucleotide triphosphate (dNTP) synthesis – a typical response to replication stress and DNA damage. Both RP-deficient zebrafish and human hematopoietic cells showed activation of the ATR/ATM-CHK1/CHK2/p53 pathway. Other features of RP deficiency included an imbalanced dNTP pool, ATP depletion and AMPK activation. Replication stress and DNA damage in cultured cells in non-DBA models can be decreased by exogenous nucleosides. Therefore, we treated RP-deficient zebrafish embryos with exogenous nucleosides and observed decreased activation of p53 and AMPK, reduced apoptosis, and rescue of hematopoiesis. Our data suggest that the DNA damage response contributes to p53 activation in cellular and zebrafish models of DBA. Furthermore, the rescue of RP-deficient zebrafish with exogenous nucleosides suggests that nucleoside supplements could be beneficial in the treatment of DBA.